Mitoxantrone and amsacrine: two important agents for the treatment of acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL).
Arlin
Z A
ZA
New York Medical College, Valhalla.
D000677:Amsacrine / Q000008:administration & dosage / Q000627:therapeutic use*; D003630:Daunorubicin / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012074:Remission Induction
D000677:Amsacrine; D008942:Mitoxantrone; D003630:Daunorubicin